[关键词]
[摘要]
目的 调查肿瘤患者使用脂肪乳注射液的用药情况,为合理用药提供参考。方法 采用回顾分析法,从郑州大学附属肿瘤医院2016年1-12月所有使用脂肪乳注射液肿瘤患者的病例中随机抽取1500份,根据相关标准就脂肪乳的适应证、药物选择、配伍合理性、给药途径等方面进行专项点评。结果 调查的1 500例肿瘤患者中,以围手术期患者居多,占68.2%。528例用药不合理,占35.2%;其中,适应症不适宜占16.1%,药物选择不适宜占44.5%,用法用量不适宜占50.6%,配伍禁忌占18.3%。结论 该院脂肪乳注射液临床应用不合理现象较为明显,需采取措施强化该类药品的规范使用。
[Key word]
[Abstract]
Objective To evaluate the clinical application of Fat Emulsion Injection in tumor patients and provide references for rational drug use. Methods A total of 1500 cases administered with Fat Emulsion Injection during January and December 2016 in Affiliated Cancer Hospital of Zhengzhou University were collected randomly and evaluated with the relevant standards. Results From the investigation of a total of 1 500 patients with cancer, fat Emulsion Injection was mainly used in the surgery department (68.2%). Of 1500 cases, unreasonable medical records accounted for 35.2%; inappropriate indication accounted for 16.1%, inappropriate selection of drugs accounted for 44.5%, incorrect dosage accounted for 50.6%, and incompatibility accounted for 18.3%. Conclusion Unreasonable use of Fat Emulsion Injection in the hospital is prevalent, therefore, measures should be taken to strengthen the standard use of this kind of drugs.
[中图分类号]
[基金项目]
国家自然科学基金项目(81302796)